News
BEIJING--China’s vaccine specialist CanSino Biologics Inc. has won a patent approval from Beijing for its COVID-19 vaccine candidate Ad5-nCOV, state media reported, citing documents from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback